Investment in ADC Biotechnology by Maven

, ,

2017-10-10T14:55:48+00:00

Maven invests in ADC Biotechnology HMT, led by Partner Paul Read advised Maven Capital Partners (“Maven”) on their investment in anti-cancer drugs manufacturer ADC Biotechnology (“ADC”). ADC Bio operates in the highest growth sector within oncology therapeutics and has developed a unique patented Lock-Release technology for the development and manufacture [...]

Disposal of Foresight Partnership Ltd

, ,

2017-06-06T10:54:34+00:00

Disposal of Foresight Partnership Ltd HMT LLP, led by partner Andrew Thomson, director Holly Bedford and senior manager Matthew Gordon-Smith, advised the shareholders of Foresight Partnership Limited, one of the leading niche governance and organisational development consultancies in healthcare in the UK, on their disposal to GE Healthcare Finnamore. The [...]

Investment in Disposal Cubicle Curtains Limited by Beringea

, , ,

2017-06-06T10:54:34+00:00

Investment in Disposal Cubicle Curtains Limited by Beringea HMT, led by associate director Peter Wear, advised Beringea LLP (“Beringea”),  the growth capital investor that manages the Proven Venture Capital Trusts, on their £3 million investment in Disposable Cubicle Curtains Limited (“DCCL”), trading as All in One Medical. DCCL manufactures and [...]

Disposal of Basan UK Limited

,

2017-06-06T10:54:36+00:00

Disposal of Basan UK Limited HMT advised Cleanroom Products (Holdings) Limited on the disposal of Basan UK Limited ("Basan"), a leading supplier of cleanroom consumables and equipment for the pharmaceutical, medical, engineering and food industries, to VWR International LLC ("VWR"), a supplier and distributor of scientific supplies to the research [...]

MBO of Tessella Limited

, ,

2016-03-02T15:34:03+00:00

Management Buyout of Tessella Limited HMT, led by partner Andrew Thomson and associate director Holly Bedford, advised Newco and existing management on the management buyout of Tessella Limited. Mobeus Equity Partners supported the buyout and founder Kevin Gell retains a significant minority stake plus continues to serve as a board [...]

Imperial Innovations Group PLC Invests in Stanmore Implants

, ,

2017-06-06T10:54:37+00:00

Imperial Innovations Group PLC Invests in Stanmore Implants HMT advised Imperial Innovations, the UK's leading technology commercialisation and investment company, on its £4 million investment in Stanmore Implants. Stanmore Implants is a specialist in the design and manufacture of patient specific implants for complex orthopaedic reconstructions. Stamnore currently focuses on [...]

Disposal of in4tek Limited to Civica Group Ltd

,

2017-06-06T10:54:37+00:00

Disposal of in4tek Limited to Civica Group Ltd HMT advised the shareholders of in4tek Limited on its disposal to Civica Group Ltd. in4tek, based in Altrincham, specialises in application software and related services for the health and social care sectors. Its integrated product suite, which enables the management of all [...]

Wound Solutions completes round of fundraising

,

2016-02-26T12:53:00+00:00

Wound Solutions completes round of fundraising Wound Solutions Limited, exclusively advised by HMT, have successfully raised £2.5m in development funding from both new and existing investors. This will enable Wound Solutions to bring to market its initial product. Wound Solutions is involved in developing an innovative solution for the healing [...]

Acquisition by Premier Research Arizona LLC of Pivotal Research Centers Inc

, ,

2017-06-06T10:54:38+00:00

Acquisition by Premier Research Arizona LLC of Pivotal Research Centers Inc HMT advised Premier Research Group (“PRG”), an international pharmaceutical services group, on the acquisition of Pivotal Research Centers Inc (“Pivotal”), funded by ECI Partners. The acquisition continues PRG’s buy and build growth strategy to build a leading international contract [...]

MBO of Sunset Dawn Group Limited

, , ,

2017-06-06T10:54:38+00:00

MBO of Sunset Dawn Group Limited HMT, led by partner Andrew Thomson, advised the management team of Sunset Dawn Group Limited (“Sunset Dawn”) on its management buyout. Sunset Dawn was originally established as a buy and build to take advantage of a fragmented market. It acquired Apollo Medical Systems, (“AMS”) [...]

Premier Research Group plc acquisitions of ARS Clinical and D-TARGET

, ,

2017-06-06T10:54:38+00:00

Premier Research Group plc acquires ARS Clinical and D-TARGET for up to £11.1m and £6.9m respectively HMT advised Premier Research Group plc (“PRG”), an international pharmaceutical services group, on the simultaneous acquisitions of ARS Clinical (“ARS”) and D-TARGET (“DT”) for up to £11.1m and £6.9m respectively. Both transactions have been [...]

Acquisition of Healthcare Software Systems Limited

, , ,

2017-06-06T10:54:40+00:00

Acquisition of Healthcare Software Systems Limited HMT acted as reporting accountants for Sunset Dawn Limited on its acquisition of Healthcare Software Systems Limited. HSS was established in 1987 and is now a leading provider of radiology information management solutions in the healthcare industry.  This has been brought about by the [...]

Premier Research plc acquired Scirex Corporation Group for up to £20 million

, ,

2017-06-06T10:54:40+00:00

Premier Research plc acquired Scirex Corporation Group for up to £20 million HMT advised Premier Research Group plc (“PRG”), an international pharmaceutical services group, on the acquisition of the Scirex Corporation Group (“Scirex”) for up to £20 million. Scirex, a subsidiary of Omnicom Inc, the global leader in marketing communications, [...]

Broker Network Holdings plc acquired Towry Law Insurance Brokers Limited

, ,

2017-06-06T10:54:40+00:00

Broker Network Holdings plc acquired Towry Law Insurance Brokers Limited HMT provided transaction support services for Broker Network Holdings plc on the acquisition of Towry Law Insurance Brokers Ltd (“TLIB”). Formed in 1994, Broker Network’s is an AIM listed network of over 130 independent "community" insurance brokers. The Members, who [...]

Acquisition of Apollo Medical Systems Limited

, , ,

2017-06-06T10:54:40+00:00

Acquisition of Apollo Medical Systems Limited HMT acted as reporting accountants for Sunset Dawn Limited on its acquisition of Apollo Medical Systems Limited (“Apollo”).   Apollo was established in 2000 and is now a well-established and successful provider of IT solution to the National Health Service (“NHS”). This has been [...]

Premier Research Plc acquired PharmData Inc for up to £12.0 million and Imform GmbH for up to £4.5 million

, ,

2016-02-26T13:52:48+00:00

Premier Research Plc acquired PharmData Inc for up to £12.0 million and Imform GmbH for up to £4.5 million HMT advised Premier Research Group plc (“PRG”) an international pharmaceutical services group on the acquisition of Pharmdata Inc (“PharmData”) and Imform GmbH (“Imform”) for up to £12.0 million and £4.5 million [...]

Premier Research plc acquired EPA Euro Pharma GmbH for £3.2 million

, ,

2016-02-26T13:54:50+00:00

Premier Research Plc acquired EPA Euro Pharma GmbH for £3.2 million HMT aadvised Premier Research Group Plc (“PRG”) an international pharmaceutical services group on the acquisition of EPA Euro Pharma GmbH (“EPA”) for £3.2 million. EPA is a contract research organisation (“CRO”), based near Frankfurt, providing a broad range of [...]

Initial public offering of Premier Research Group

, , , ,

2017-06-06T10:54:41+00:00

Initial Public Offering of Premier Research Group HMT advised and acted as reporting accountants to Premier Research Group on the AIM flotation in December 2004. The flotation raised £8 million before costs at a placing price of 40p per share, and was accompanied by the raising of a £3.5 million [...]

Secondary buyout of Chiltern Invadex Holdings

, ,

2016-02-26T14:04:03+00:00

Secondary buyout of Chiltern Invadex Holdings HMT provided the financial due diligence in respect of the secondary buyout of Chiltern Invadex Holdings on behalf of a Newco funded by Aberdeen Murray Johnstone and Bank of Scotland. CI was founded in 1974 and was the subject of an original MBO in [...]

Acquisition of Premier Research (USA)

,

2017-06-06T10:54:41+00:00

Acquisition of Premier Research (USA) HMT advised CRC Development Limited (“CRC”) on its acquisition of Premier Research, a contract Clinical Research Organisation (“CRO”) based in Philadelphia, USA. Originally founded in 2002 by Dr Guy Patrick, Dr Simon Yaxley and Mr Tim Carden, all of whom have extensive experience of the [...]

Refinancing of Advanced Clinical Sciences Corporation Ltd and acquisition of CRC GmbH (Switzerland) and CRC SRL (Italy)

, , ,

2017-06-06T10:54:41+00:00

Refinancing of Advanced Clinical Sciences Corporation Limited and acquisition of CRC GMBH (Switzerland) and CRC SRL (Italy) HMT advised its client Advanced Clinical Research Corporation Limited (“ACSC”) in the refinancing of its growing operations and the acquisition of the pan European CRC Group. ACSC was founded in 2002 by Dr [...]

Management buyout of RBF Group

, ,

2016-02-26T14:26:24+00:00

Management buyout RBF Group HMT advised the management team in its buyout of RBF Group, the Southend on Sea based manufacturer of healthcare products and heatshields, having been recommended to management by Northern Venture Managers.  RBF Group has premises in Southend on Sea, Salford and Cambridge. The business operates in [...]